Promising Partnerships, Stock Price Updates and Participation in Upcoming Healthcare Conferences - Research Report on Quest

  Promising Partnerships, Stock Price Updates and Participation in Upcoming
 Healthcare Conferences - Research Report on Quest Diagnostics, Cigna, Arena,
                           Theravance, and Volcano

Editor Note: For more information about this release, please scroll to bottom

PR Newswire

NEW YORK, November 29, 2013

NEW YORK, November 29, 2013 /PRNewswire/ --

Today, Analysts' Corner announced new research reports highlighting Quest
Diagnostics Inc. (NYSE: DGX), Cigna Corp. (NYSE: CI), Arena Pharmaceuticals,
Inc. (NASDAQ: ARNA), Theravance Inc. (NASDAQ: THRX), and Volcano Corporation
(NASDAQ: VOLC). Today's readers may access these reports free of charge -
including full price targets, industry analysis and analyst ratings - via the
links below.

Quest Diagnostics Inc. Research Report

On November 26, 2013, Quest Diagnostics Inc. (Quest Diagnostics) reported that
it will present at the Piper Jaffray 25th Annual Healthcare Conference in New
York City, in which the Company's President and CEO Steve Rusckowski will
review Quest Diagnostics' vision, goals and five-point strategy. The Company
informed that the presentation is scheduled for Tuesday, December 3, 2013, at
9:30 a.m. ET. Quest Diagnostics informed that the live webcast of the
presentation will be available on the Company website. The Company added that
archive of the live webcast, two hours following the conclusion of the live
event, can be accessed at the Company's website until January 2, 2014. The
Full Research Report on Quest Diagnostics Inc. - including full detailed
breakdown, analyst ratings and price targets - is available to download free
of charge at:

http://www.AnalystsCorner.com/r/full_research_report/05ba_DGX

--

Cigna Corp. Research Report

On November 26, 2013, Cigna Corp. (Cigna) announced that the Company, along
with Kent Hospital, has entered into a multi-year contract that adds the
hospital and its employed physicians to Cigna's network of participating
hospitals and doctors in Rhode Island, with effect from December 1, 2013.
Cigna stated that with effect of this contract, its customers receiving health
care services from Kent Hospital or its doctors are now covered at the
in-network benefit level, in accordance to the terms of their health care
benefits plan. Don Curry, Cigna's President and General Manager for New
England, commented, "We welcome Kent Hospital to the Cigna network and are
pleased that our Rhode Island customers will now have more options available
when they need access to quality health care." Sandra L. Coletta, Chief
Operating Officer, Care New England and President and CEO, Kent Hospital,
added, "Kent Hospital's partnership with Cigna means that more people will
have access to an extensive array of health care services. Helping more people
to be healthy and live healthy lives is always an excellent outcome." The Full
Research Report on Cigna Corp. - including full detailed breakdown, analyst
ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/7307_CI

--  

Arena Pharmaceuticals, Inc. Research Report

On November 26, 2013, Arena Pharmaceuticals, Inc.'s (Arena) stock increased
5.44%, ending the day at $6.40. Over the previous three trading sessions,
shares of Arena increased 11.89% compared to the Nasdaq Composite which also
increased 1.22% during the same period. The Full Research Report on Arena
Pharmaceuticals, Inc. - including full detailed breakdown, analyst ratings and
price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/6a95_ARNA

--

Theravance Inc. Research Report

On November 21, 2013, Theravance Inc. (Theravance) reported that it will
participate at the 25th Annual Piper Jaffray Healthcare Conference to be held
on December 3 to December 4, 2013 at The New York Palace, New York City, New
York. Theravance stated that its CEO, Rick E Winningham, will present on
Tuesday, December 3, 2013, at 9:30 a.m. EST, and the live webcast of the
presentation will be available at the Company's website. The Full Research
Report on Theravance Inc. - including full detailed breakdown, analyst ratings
and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/fa70_THRX

--

Volcano Corporation Research Report

On November 25, 2013, Volcano Corporation (Volcano) reported that it will take
part in the Piper Jaffray 25th Annual Health Care Conference on Tuesday,
December 3, 2013. The Company stated that the presentation will be given by
Scott Huennekens, President and CEO, which is slated to start at 1:00 p.m. EST
(10:00 a.m. PST). Volcano added that the presentation can be accessed via the
Company's website. The Full Research Report on Volcano Corporation - including
full detailed breakdown, analyst ratings and price targets - is available to
download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/14bf_VOLC

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we
    are only human and are prone to make mistakes. If you notice any errors or
    omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Namrata Maheshwari,
CFA, has only reviewed the information provided by Equity News Network in this
article or report according to the Procedures outlined by Equity News Network.
Equity News Network is not entitled to veto or interfere in the application of
such procedures by the outsourced provider to the articles, documents or
reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

AnalystsCorner.com

SOURCE Analysts' Corner

Contact: Joe Thomas; +1-310-496-8071 (North America)
 
Press spacebar to pause and continue. Press esc to stop.